Search

Your search keyword '"Tetart F"' showing total 307 results
Start Over Author "Tetart F"
307 results on '"Tetart F"'

1. French national protocol for diagnosis and management of epidermal necrolysis in adults (Stevens-Johnson syndrome and toxic epidermal necrolysis)

Author

Ingen-Housz-Oro, S., Matei, I., Gaillet, A., Gueudry, J., Zaghbib, K., Assier, H., Hua, C., Bensaid, B., Colin, A., Ouedraogo, R., Redlich, J., Courtois, E., Chazelas, K., Sbidian, E., Nakad, L., Bequignon, E., Terkmane, N., Gaultier, F., Schlemmer, F., Do-Pham, G., Barbaud, A., Lebrun-Vignes, B., Hoffmann, C., Mahé, P.-J., Le Floch, R., Bernier, C., Vabres, B., Milpied, B., Delcampe, A., Tétart, F., Tauber, M., Staumont-Sallé, D., Dezoteux, F., Descamps, V., Misery, L., Bursztejn, A.-C., Dereure, O., Amazan, E., Le Bidre, E., Le Pallec, S., Lagier, C., Laroche, A., Ferrat, E., Wolkenstein, P., and de Prost, N.

Published
2024
Full Text
View/download PDF

6. Acute generalized exanthematous pustulosis: European expert consensus for diagnosis and management.

Author

Tetart, F., Walsh, S., Milpied, B., Gaspar, K., Vorobyev, A., Tiplica, G. S., Didona, B., Welfringer‐Morin, A., Kucinskiene, V., Bensaid, B., Marvanova, E., Salavastru, C., Brezinova, E., Chua, S. L., Lovgren, M. L., Hammers, C. M., Barbaud, A., Mortz, C. G., Horvath, B., and Meyersburg, D.

Subjects
*DRUG eruptions, *DRUG allergy, *DRUG side effects, *DERMATOLOGISTS
Abstract

Acute generalized exanthematous pustulosis (AGEP) is a rare, usually drug‐induced, acute pustular rash. Despite the lack of strong data supporting the effectiveness of topical or systemic corticosteroids in this drug reaction, they are widely used. More generally, there is no consensus on the diagnostic modalities and the management of patients with AGEP. We aimed to provide European expert recommendations for the diagnosis and management or patients with AGEP. Members of the ToxiTEN group of the European Reference Network (ERN)‐skin, all dermatologists and/or allergologists with expertise in drug reactions, elaborated these recommendations based on their own experience and on a review of the literature. Recommendations were separated into the following categories: professionals involved, assessment of the diagnosis of AGEP, management of the patient and allergological work‐up after the acute phase. Consensus was obtained among experts for the list of professionals involved for the diagnosis and management of AGEP, including the minimum diagnostic work‐up, the setting of management, the treatments, the modalities and the timing of allergological work‐up and follow‐up. European experts in drug allergies propose herein consensus on the diagnosis and management of patients with AGEP. A multidisciplinary approach is warranted, including dermatologists, allergologists and pharmacovigilance services. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

8. Rashs cutanés sous KAFTRIO/KALYDECO

Author

Quatremare, M., primary, Tetart, F., additional, Boulay, C., additional, Montastruc, F., additional, Revol, B., additional, Pramil, S., additional, Morisse Pradier, H., additional, Marguet, C., additional, and Couderc, L., additional

Published
2024
Full Text
View/download PDF

9. Baseline patient characteristics, physician-assessed effectiveness, patient-reported outcomes, and safety in adult and adolescent patients with atopic dermatitis in France treated with dupilumab: Real-world insights 1 year into the GLOBOSTAD multinational prospective observational study

Author

Fougerousse, A.C., primary, Tauber, M., additional, Seneschal, J., additional, Du-Thanh, A., additional, Tetart, F., additional, Becherel, P.A., additional, Wu, J., additional, Ardeleanu, M., additional, and Bosman, K., additional

Published
2024
Full Text
View/download PDF

14. Management of ocular involvement in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis: french national audit of practices, literature review, and consensus agreement

Author

Thorel, D., Ingen-Housz-Oro, S., Royer, G., Delcampe, A., Bellon, N., Bodemer, C., Welfringer-Morin, A., Bremond-Gignac, D., Robert, M. P., Tauber, M., Malecaze, F., Dereure, O., Daien, V., Colin, A., Bernier, C., Couret, C., Vabres, B., Tetart, F., Milpied, B., Cornut, T., Ben Said, B., Burillon, C., Cordel, N., Beral, L., de Prost, N., Wolkenstein, P., Muraine, M., and Gueudry, J.

Published
2020
Full Text
View/download PDF

15. Intérêt d’une batterie spécialisée de tests épicutanés dans une cohorte de patients adressés pour hypersensibilité à leur implant orthopédique. Une étude multicentrique du DAG

Author

Gautier, C., Giordano-Labadie, F., Marcant, P., Castelain, F., Raison-Peyron, N., Milpied, B., Kurihara, F., Bara, C., Ferrier-Le Bouedec, M.C., Pasteur, J., Tetart, F., Assier, H., Morice, C., Bernier, C., Delaunay, J., Valois, A., Boulard, C., Crepy, M.N., Leleu, C., Chasset, F., Hardy, A., and Barbaud, A.

Published
2024
Full Text
View/download PDF

23. Retrospective study on the association of human herpesvirus reactivation with severe DRESS: A description of blood and skin reactivations.

Author

Marcombes, C., Ingen‐Housz‐Oro, S., Dezoteux, F., Staumont‐Sallé, D., Milpied, B., Tetart, F., de Prost, N., Fourati, S., Ortonne, N., Kasimir, F., Prusty, B. K., and Descamps, V.

Subjects
INTENSIVE care units, SKIN biopsy, VIRUS reactivation, BLOOD sampling, VIRAL proteins, AUJESZKY'S disease virus
Abstract

Background: Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) is a severe adverse event (mortality of 10%). Its pathophysiology involves herpesviruses, particularly HHV‐6, but the exact mechanisms are still poorly understood. Objective: To describe severe cases of DRESS and especially their association with herpesvirus reactivation. Methods: This study was a multicentre case series conducted between 2007 and 2021 at five University Hospital Centres in France. The study included patients who had severe DRESS, which was defined as death, transfer to the intensive care unit (ICU), or severe damage to internal organs. We excluded patients without blood PCR sample, without a drug formally attributed or with RegiSCAR score < 6. We collected data on severity, causative drug, associated visceral damage and results of viral blood PCRs. HHV‐6 reactivation was studied in skin biopsies by detection of small non‐coding transcripts (HHV‐6 miR‐aU14) and a late viral protein (GP82/105). Results: Fifty‐two patients were included (29 female, median age 62, interquartile range (IQR) [37;72]). Eight patients (15%) died, 13 (27%) were admitted to ICU. Most patients (n = 34; 65%) had multisystem involvement: most frequent was liver (n = 46; 88%), then renal failure (n = 24; 46%). Forty patients (77%) had at least one blood viral reactivation among HHV‐6, EBV or CMV, of which 21 (53%) had at least two. Median time of blood HHV‐6 reactivation was 24 days (IQR [20;35]). HHV‐6 reactivation was demonstrated in 15 out of 20 skin biopsies, with a median time of 11 days [9;17]. Conclusions: We confirmed the high rate of HHV‐6 reactivation in severe DRESS and demonstrated cutaneous HHV‐6 reactivation using small non‐coding transcripts (HHV‐6 miR‐aU14), which preceded viral PCR positivity in blood. These results suggest that HHV‐6 reactivation during DRESS may start in skin. Furthermore, search for miR‐aU14 in skin biopsy could become a useful diagnostic tool for early detection of HHV‐6 reactivation. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

26. Éruptions eczématiformes chroniques du sujet âgé : quelle imputabilité médicamenteuse ?

Author

Bouteiller, J., primary, Grosjean, J., additional, Delaunay, J., additional, Jachiet, M., additional, Bara, C., additional, Nosbaum, A., additional, Bouschon, P., additional, Milpied, B., additional, Oro, S., additional, Assier, H., additional, Guelimi, R., additional, Valois, A., additional, Viguier, M., additional, Dezoteux, F., additional, Staumont-Sallé, D., additional, Boulard, C., additional, Brenaut, E., additional, Morice, C., additional, Raison Peyron, N., additional, Joly, P., additional, and Tetart, F., additional

Published
2022
Full Text
View/download PDF

32. Management of urticaria by French specialists compared to international guideline recommendations

Author

Berard, F., Viguier, M., Lefevre, S., Vigan, M., Barzegar, C., Boussaid, R., Hacard, F., Gabison, G., Staumont, D., Marmion, N., Pouplard, C., Delaunay, J., Badaoui, A., Nosbaum, A., Pralong, P., Castelain, F., Bouillet, L., Sarre, M.E., Vermeulen, C., Tetart, F., Bachtarzi, Z., Doutre, M.S., Martinache, C., Bara, C., Augey, F., Boccon Gibod, I., Nicolas, J.F., Maatouk, I., Mathelier Fusade, P., Soutou, B., Goujon Henry, C., Hoarau, C., Crépy, M.N., Bernier, C., Cambazard, F., Guinepain, M.T., Amsler, Emmanuelle, Du Thanh, Aurelie, and Soria, Angèle

Published
2020
Full Text
View/download PDF

38. Towards a better understanding of adult idiopathic epidermal necrolysis: a retrospective study of 19 cases

Author

Monnet, P., primary, Rodriguez, C., additional, Gaudin, O., additional, Cirotteau, P., additional, Papouin, B., additional, Dereure, O., additional, Tetart, F., additional, Lalevee, S., additional, Colin, A., additional, Lebrun‐Vignes, B., additional, Abe, E., additional, Alvarez, J.‐C., additional, Demontant, V., additional, Gricourt, G., additional, Prost, N., additional, Barau, C., additional, Chosidow, O., additional, Wolkenstein, P., additional, Hue, S., additional, Ortonne, N., additional, Milpied, B., additional, and Ingen‐Housz‐Oro, S., additional

Published
2021
Full Text
View/download PDF

42. Drug reaction with eosinophilia and systemic symptoms (DRESS) : série de 53 cas pédiatriques français

Author

Bedouelle, E., primary, Ben Said, B., additional, Tetart, F., additional, Milpied, B., additional, Welfringer-Morin, A., additional, Maruani, A., additional, Catteau, B., additional, Dezoteux, F., additional, Staumont-Sallé, D., additional, Mazereeuw-Hautier, J., additional, Abasq, C., additional, Chiaverini, C., additional, Mahe, E., additional, Delaunay, J., additional, Mallet, S., additional, Sterling, B., additional, Puzenat, E., additional, Raynal, M., additional, Collet, E., additional, and Bernier, C., additional

Published
2021
Full Text
View/download PDF

43. Hypersensibilité retardée aux traitements antituberculeux. Proposition d’une conduite à tenir pratique devant un exanthème : quand arrêter, quelles explorations allergologiques et comment réintroduire le traitement

Author

Ingen-Housz-Oro, S., Assier, H., Gener, G., Milpied, B., Soria, A., Bernier, C., Descamps, V., Tetart, F., Staumont-Sallé, D., Valeyrie-Allanore, L., Valois, A., Sassolas, B., Bensaid, B., Lebrun-Vignes, B., and Barbaud, A.

Published
2019
Full Text
View/download PDF

48. Hyperéosinophilie associée au traitement par dupilumab dans la dermatite atopique modérée à sévère : étude rétrospective multicentrique du GREAT

Author

Marcant, P., primary, Balayé, P., additional, Merhi, R., additional, Seneschal, J., additional, Tauber, M., additional, Jendoubi, F., additional, Nosbaum, A., additional, Raison-Peyron, N., additional, Du-Thanh, A., additional, Lasek, A., additional, Ferrier le Bouedec, M.-C., additional, Tetart, F., additional, Valois, A., additional, Lefevre, G., additional, Barbarot, S., additional, Soria, A., additional, Jachiet, M., additional, and Staumont-Sallé, D., additional

Published
2020
Full Text
View/download PDF

49. Drug reaction with eosinophilia and systemic symptoms (DRESS) : série de 53 cas pédiatriques français

Author

Bedouelle, E., primary, Ben Said, B., additional, Tetart, F., additional, Milpied, B., additional, Welfringer, A., additional, Maruani, A., additional, Catteau, B., additional, Dezoteux, F., additional, Staumont-Sallé, D., additional, Mazareeuw-Hautier, J., additional, Abasq-Thomas, C., additional, Chiaverini, C., additional, Mahé, E., additional, Delaunay, J., additional, Mallet, S., additional, Sterling, B., additional, Puzenat, E., additional, Raynal, M., additional, Collet, E., additional, and Bernier, C., additional

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results